Stella Pharma Corp.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -42.86% vs 16.67% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -35.05% vs 3.51% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "61.60",
          "val2": "107.80",
          "chgp": "-42.86%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-206.50",
          "val2": "-139.90",
          "chgp": "-47.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.50",
          "val2": "1.30",
          "chgp": "15.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-204.20",
          "val2": "-151.20",
          "chgp": "-35.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-3,468.90%",
          "val2": "-1,364.40%",
          "chgp": "-210.45%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 256.62% vs 17.63% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 81.56% vs 1.94% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "961.10",
          "val2": "269.50",
          "chgp": "256.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-55.50",
          "val2": "-725.30",
          "chgp": "92.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "4.10",
          "val2": "2.10",
          "chgp": "95.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-140.80",
          "val2": "-763.70",
          "chgp": "81.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-93.90%",
          "val2": "-2,821.20%",
          "chgp": "272.73%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

61.60

107.80

-42.86%

Operating Profit (PBDIT) excl Other Income

-206.50

-139.90

-47.61%

Interest

1.50

1.30

15.38%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-204.20

-151.20

-35.05%

Operating Profit Margin (Excl OI)

-3,468.90%

-1,364.40%

-210.45%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is -42.86% vs 16.67% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -35.05% vs 3.51% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

961.10

269.50

256.62%

Operating Profit (PBDIT) excl Other Income

-55.50

-725.30

92.35%

Interest

4.10

2.10

95.24%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-140.80

-763.70

81.56%

Operating Profit Margin (Excl OI)

-93.90%

-2,821.20%

272.73%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 256.62% vs 17.63% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 81.56% vs 1.94% in Mar 2024

All Annual Results